NCT01540591View on ClinicalTrials.gov

Intralipid for Repeated Implantation Failure

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

June 30, 2014

Conditions
Infertility
Interventions
DRUG

intralipid

IV infusion of intralipid 20% between day4 and 9 of ovarian stimulation \& another dose when got pregnant within the 1st week of positive pregnancy test

DRUG

Saline

Saline 0.9% IV infusion between day4 and 9 of ovarian stimulation \& another dose when got pregnant within the 1st week of positive pregnancy test

Trial Locations (1)

12211

Kasr Al-ainy hospital, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT01540591 - Intralipid for Repeated Implantation Failure | Biotech Hunter | Biotech Hunter